The Robinson campus handled administration of Bayer’s operations in North America and some product development.
The closure is a result of a companywide consolidation plan, which includes eliminating 12,000 jobs worldwide. The decision to consolidate comes after the drugmaker’s $63 billion acquisition of seed maker Monsanto last year.
“In the U.S., we are beginning to implement this by consolidating administrative functions,” Bayer told The Post-Gazette.
The decision will affect 569 company employees and 96 contractors. Bayer has contacted affected employees.
The closure will take place over two years.
More articles on pharmacy:
House panel launches drug-pricing probe of 12 pharma companies
Key thoughts on controlling pharmacy spend for hospitals
Dispensary of Hope’s pharmaceutical director Dr. Hillary Blackburn on what makes a dynamic, influential leader
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.